Zogenix, Inc. ZGNX
Set alert
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 1.50B
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -33.77
- Beta
- 0.90
- Short ratio
- 1.64
- Inst. own
- 110.60%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 28, 2022
- 50-d avg
- 23.18
- 200-d avg
- 17.40
- 1y target
- 38.00
News
2 years ago globenewswire.com
Needle-Free Drug Injection Systems Business Analysis Report 2023-2030 Featuring AKRA Dermojet, Crossject, D`Antonio Consultants, PharmaJet, and Zogenix
Dublin, Aug. 01, 2024 (GLOBE NEWSWIRE) -- The "Needle-Free Drug Injection Systems - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for…
4 years ago globenewswire.com
Zogenix To Present New Long-term Data on FINTEPLA® (fenfluramine) in Lennox-Gastaut Syndrome (LGS) at AAN 2022
EMERYVILLE, Calif., March 04, 2022 (GLOBE NEWSWIRE) -- Zogenix (Nasdaq: ZGNX), a global biopharmaceutical company developing and commercializing rare disease therapies, announced that new data from…
4 years ago zacks.com
Zogenix (ZGNX) Reports Q4 Loss, Tops Revenue Estimates
Zogenix (ZGNX) delivered earnings and revenue surprises of -8.89% and 1.46%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
4 years ago fool.com
Why Zogenix Flew Higher Before Leveling Off This Week
The company attracts a determined suitor from abroad.
4 years ago stockmarket.com
Top Biotech Stocks To Buy Now? 5 For Your Late January Watchlist
Which biotech stocks are you watching today?
4 years ago zacks.com
Zogenix (ZGNX) Stock Surges on Acquisition Offer From UCB
Belgium-based UCB is set to acquire Zogenix (ZGNX) for a total transaction value of $1.9 billion in cash. The transaction is likely to be completed by second-quarter 2022.
4 years ago zacks.com
Zogenix (ZGNX) Stock Jumps 65.7%: Will It Continue to Soar?
Zogenix (ZGNX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in…
4 years ago investorplace.com
ZGNX Stock: The $1.9B UCB Deal That Has Zogenix Shares Zooming Higher Today
Zogenix (ZGNX) stock is skyrocketing on Wednesday following news that UCB (UCBJY) intends to acquire the company in a $1.9 billion deal. The post ZGNX Stock: The $1.9B UCB Deal That Has Zogenix…
4 years ago fool.com
Why Zogenix Stock Is on Fire Today
A buyout deal is lighting a fire underneath the biotech's shares today.
4 years ago benzinga.com
Why Zogenix Shares Are Soaring Today
Zogenix Inc (NASDAQ: ZGNX) is trading significantly higher Wednesday morning after the company announced it received a proposal to be acquired by UCB for approximately $1.9 billion. Under terms of…
4 years ago pulse2.com
Zogenix Stock (ZGNX): Why The Price Went Up Substantially Today
The stock price of Zogenix, Inc. (NASDAQ: ZGNX) increased by over 60% pre-market today. This is why it happened.
4 years ago benzinga.com
UCB to Buy Epilepsy-Focused Zogenix In $1.9B Deal: See The Highlights
Belgian-based UCB SA (OTC: UCBJF) has agreed to buy Zogenix Inc (NASDAQ: ZGNX), a U.S. maker of drugs to treat seizures and rare diseases, for $1.9 billion, expanding its portfolio to treat epilepsy.…
4 years ago globenewswire.com
Zogenix To Present New FINTEPLA® (fenfluramine) Data at AES 2021
Data add to the growing body of evidence supporting the efficacy and safety profile of FINTEPLA for the treatment of Dravet syndrome Data add to the growing body of evidence supporting the efficacy…
4 years ago benzinga.com
Why Are Zogenix's Shares Gaining Today?
The FDA has granted Priority Review to Zogenix Inc's (NASDAQ: ZGNX) supplemental marketing application seeking approval for Fintepla (fenfluramine) in Lennox-Gastaut syndrome (LGS) childhood-onset…
4 years ago fool.com
4 of the Fastest-Growing Stocks on the Planet Through 2024
Wall Street projects aggregate sales growth of 509% to 3,324% for these stocks.
4 years ago seekingalpha.com
Zogenix, Inc. (ZGNX) CEO Dr. Stephen Farr on Q3 2021 Results - Earnings Call Transcript
Zogenix, Inc. (ZGNX) CEO Dr. Stephen Farr on Q3 2021 Results - Earnings Call Transcript
4 years ago benzinga.com
Recap: Zogenix Q3 Earnings
Zogenix (NASDAQ:ZGNX) reported its Q3 earnings results on Thursday, November 4, 2021 at 04:01 PM. Here's what investors need to know about the announcement.
5 years ago globenewswire.com
Zogenix Reports Granting of Inducement Awards
EMERYVILLE, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Zogenix (NASDAQ: ZGNX) today announced that the compensation committee of the company's board of directors granted inducement awards to…
5 years ago seekingalpha.com
Zogenix, Inc.: Still Cautiously Optimistic
Today, we revisit biopharma name Zogenix, Inc. for the first time since early this year.
5 years ago benzinga.com
Zogenix's Fintepla Shows Long-Term Seizure Frequency Reductions In Childhood Epilepsy
Zogenix Inc (NASDAQ: ZGNX) has announced interim data from an ongoing 12-month Phase 3 open-label extension (OLE) study of Fintepla (fenfluramine) in Lennox-Gastaut syndrome (LGS). Data showed that…